Nox Health announced a strategic growth investment from Vestar Capital Partners, a U.S. middle-market private equity firm. The investment will help Nox accelerate development of its sleep diagnostic technology and services, and adoption of its value-based comprehensive sleep management solutions for employers and health plans.
“Sleep is an attractive healthcare category with sustainable long-term growth tailwinds and significant unmet demand,” said Mike Vaupen, Managing Director at Vestar Capital Partners. “Nox has built a differentiated and market-leading set of diagnostic devices, workflow software, and value-based care management services that support a patient’s entire sleep care journey.”
Canaccord Genuity served as financial advisor to Nox Health, and Bryan Cave Leighton Paisner acted as its legal counsel. Solomon Partners served as financial advisor to Vestar, and Kirkland & Ellis provided legal counsel. Read more.
